Lilly Exploring Strategic Alternatives for Animal Health Biz Post author:Sam Post published:January 31, 2018 Post category:BioPharma Sluggish growth is the main driver for the decision.. Source: BioSpace You Might Also Like Little Exonics Adds Merck's Larger-Than-Life R&D Chief to Its Board of Directors January 29, 2018 Juniper Pharma Reports Second Quarter 2017 Financial And Operating Results August 3, 2017 Biotech Loses a Legend: Founder and Longtime CEO Dies at 71 May 14, 2017